![](/content/dam/pwc/us/en/industries/health-industries/health-research-institute/assets/next-in-health-podcast-img.png/jcr:content/renditions/cq5dam.thumbnail.319.319.png)
Next in Health: The 2025 Outlook for Health Services
Discover key insights from PwC's 2025 healthcare outlook on AI, policy shifts, and resilience amid rising costs, competition, and Medicare & Medicaid-driven growth.
Discover key insights from PwC's 2025 healthcare outlook on AI, policy shifts, and resilience amid rising costs, competition, and Medicare & Medicaid-driven growth.
President Donald Trump is expected to maintain his strong stance on deregulation and prioritize policies that address healthcare access and costs.
Inflation Reduction Act (“IRA”) Impact on Medicare Advantage-Prescription Drug (“MA-PD”) and Prescription Drug Plans (“PDP”)
Learn how organizations can start addressing the proposed updates to the HIPAA Security Rule and effectively manage the impact.
PwC's approach to helping healthcare leaders manage the aftermath of a cyber breach and focus on business operations and customer relationships.
PwC deals leaders Roel van den Akker and Nick Donkar provide insights into M&A in 2024 and offer a preview of what lies ahead.
Emerging biotech companies are poised to revolutionize healthcare, with board members playing a critical role in navigating this complex, regulated industry.
PwC's U.S. Healthcare Climate Survey reveals key insights into healthcare organizations' climate strategies, disparities across sectors, sustainability perceptions, and the impact on human health.
Discover key insights from PwC's US Consumer Healthcare Survey on costs, tech adoption, trust, and strategies to address consumer concerns and improve care.
Health services deal volumes through November 15 declined by 9 percent from 2023 levels but continued to show resilience from peak volumes of 2022.
With a confluence of factors pointing towards significant deal opportunities in 2025, industry players must remain agile and ready.
PwC specialists share strategies for medtech companies to drive growth, focusing on technology investments, cultural transformation, and mergers & acquisitions in today's complex market landscape.